Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,695.00
+15.00 (0.41%)
At close: Apr 10, 2026
Market Cap80.34B -6.7%
Revenue (ttm)108.41B +4.4%
Net Income3.67B +2.4%
EPS146.00 +256.1%
Shares Out21.74M
PE Ratio25.31
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,753
Average Volume45,012
Open3,680.00
Previous Close3,680.00
Day's Range3,640.00 - 3,735.00
52-Week Range3,200.00 - 5,090.00
Beta0.49
RSI50.57
Earnings DateApr 13, 2026

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2025, KOSDAQ:142280's revenue was 108.41 billion, an increase of 4.39% compared to the previous year's 103.85 billion. Earnings were 3.67 billion, an increase of 2.38%.

Financial Statements